The purpose of the Rodent Animal Biosafety Level 3 (ABSLs) Core is to provide investigators with the opportunity to advance research in bioterrorism and emerging infectious diseases through the use of a fully operational rodent facility. Small animal models have played a critical role in investigations of infectious diseases of importance to humans. In particular, rodent models have been successfully used to develop and test vaccines and other prevention strategies, to evaluate the efficacy and toxicity of therapeutic agents, to develop diagnostics, and to explore pathogenesis. The Rodent ABSLs Core at UC Irvine consists of a stateof- the-art, fully certified ABSLs facility offering investigators resources to conduct research on Category A, B and C pathogens, including those designated as select agents. Although designed primarily for small animal work, the ABSL3 is organized so that non-animal work with select agents can also be accommodated. Through a recharge procedure, use of the facility will be offered to investigators in academia and in industry throughout region IX and beyond;a committee and a process for allocating temporary space to potential users has been developed. Moreover, the laboratory is set up to provide not only space but also trained, dedicated in-house personnel to conduct experiments designed and supervised by Principal Investigators at UC Irvine or other institutions. The facility will offer the opportunity to conduct aerosol challenge studies of NIAID category A, B, or C priority pathogens and emerging infectious diseases in order to investigate pathogenic mechanisms and develop vaccines and rapid diagnostic tests of inhaled organisms. The Rodent ABSLs Core sets out to accomplish two specific aims: i) Maintain an infrastructure to ensure the availability of a regional ABSLs facility for use by investigators in academia and industry. The Core will maintain a process for space allocation and a recharge unit for facility use and for technical support;2) Establish and maintain a small animal aerosol challenge unit in the ABSLs facility. Experiments will be conducted to validate the unit, characterize biophysical properties of aerosolized bacteria, and develop a mouse model of pulmonary infection to advance research in inhaled infections. The Rodent ABSLs Core will serve as a critical regional resource for collaborative pathogenesis, vaccine and diagnostic studies.

Public Health Relevance

Protecting the public from bioterrorist threats and emerging infectious diseases is a major public health priority. Maintaining a Rodent ABSLs Core, with the capacity to conduct experiments with inhaled pathogens, will provide critical support to research and development activities designed to facilitate the next generation of therapeutics, diagnostics and vaccines against the NIAID Category A-C priority pathogens and emerging infections diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI065359-06
Application #
8069278
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
6
Fiscal Year
2010
Total Cost
$98,259
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Tsai, Wen-Yang; Youn, Han Ha; Tyson, Jasmine et al. (2018) Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections. Emerg Infect Dis 24:1355-1359
Thongsripong, Panpim; Chandler, James Angus; Green, Amy B et al. (2018) Mosquito vector-associated microbiota: Metabarcoding bacteria and eukaryotic symbionts across habitat types in Thailand endemic for dengue and other arthropod-borne diseases. Ecol Evol 8:1352-1368
Katzelnick, Leah C; Ben-Shachar, Rotem; Mercado, Juan Carlos et al. (2018) Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua. Proc Natl Acad Sci U S A 115:10762-10767
Clemens, Daniel L; Lee, Bai-Yu; Horwitz, Marcus A (2018) The Francisella Type VI Secretion System. Front Cell Infect Microbiol 8:121
Huwyler, Camille; Heiniger, Nadja; Chomel, Bruno B et al. (2017) Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development. Microb Ecol 74:474-484
Norris, Michael H; Heacock-Kang, Yun; Zarzycki-Siek, Jan et al. (2017) Burkholderia pseudomallei natural competency and DNA catabolism: Identification and characterization of relevant genes from a constructed fosmid library. PLoS One 12:e0189018
Marques, Adriana R; Yang, Xiuli; Smith, Alexis A et al. (2017) Citrate Anticoagulant Improves the Sensitivity of Borreliella (Borrelia) burgdorferi Plasma Culture. J Clin Microbiol 55:3297-3299
Nualnoi, Teerapat; Norris, Michael H; Tuanyok, Apichai et al. (2017) Development of Immunoassays for Burkholderia pseudomallei Typical and Atypical Lipopolysaccharide Strain Typing. Am J Trop Med Hyg 96:358-367
Parameswaran, Poornima; Wang, Chunling; Trivedi, Surbhi Bharat et al. (2017) Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections. Cell Host Microbe 22:400-410.e5
Bortell, Nikki; Flynn, Claudia; Conti, Bruno et al. (2017) Osteopontin Impacts West Nile virus Pathogenesis and Resistance by Regulating Inflammasome Components and Cell Death in the Central Nervous System at Early Time Points. Mediators Inflamm 2017:7582437

Showing the most recent 10 out of 467 publications